Press release
Radiotheranostics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Radiotheranostics
What Is the Expected Radiotheranostics Market Size During the Forecast Period?
In the past few years, the market size of radiotheranostics has expanded quickly. Projected growth from $8.79 billion in 2024 to $10.07 billion in 2025, at a compound annual growth rate (CAGR) of 14.6%, is expected. Factors contributing to the historical period's growth include the progression in nuclear medicine, an increase in cancer incidences, the creation of personalized medical treatments, advancements in radiopharmaceuticals, and regulatory confirmations and standards.
In the coming years, the market size for radiotheranostics is anticipated to experience notable expansion, with projections estimating the market value at $16.94 billion in 2029, signifying a compound annual growth rate (CAGR) of 13.9%. This predicted growth during the forecast period can be ascribed to advances in targeted cancer treatment, surge in oncology research, increasing chronic diseases, and developments in theranostic applications. Key trends foreseen within this period involve the development of theranostic radiopharmaceuticals, diversification of applications beyond the field of oncology, tailor-made radiopharmaceuticals, utilisation of nanotechnology in radiotheranostics, and alterations in regulatory parameters and standardization.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12270
What Are the High-Growth Segments in the Radiotheranostics Market?
The radiotheranostics market covered in this report is segmented -
1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes
2) By Approach: Targeted Therapeutic, Targeted Diagnostic
3) By Application: Oncology, Non-Oncology
4) By End-Users: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Technetium-99: Technetium-99m, Technetium-99 Pertechnetate
2) By Gallium-68: Gallium-68 DOTATATE, Gallium-68 PSMA
3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment, Iodine-131 For Hyperthyroidism Treatment
4) By Iodine-123: Iodine-123 For Thyroid Scans, Iodine-123 For Cardiac Imaging
5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging, FDG For Brain Imaging
6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer, Yttrium-90 For Radioimmunotherapy
7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer, Lutetium-177 DOTATATE For Neuroendocrine Tumors
8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy, Copper-67 In Clinical Trials
9) By Copper (Cu) 64: Copper-64 For PET Imaging, Copper-64 For Radiotherapy
10) By Other Radioisotopes: Radium-223, Samarium-153, Other Emerging Radioisotopes In Theranostics
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12270&type=smp
What Key Drivers Are Expected to Influence Future Radiotheranostics Market Growth?
The radiotheranostics market is predicted to grow due to the rising instances of cancer. Cancer is a disease in which certain body cells multiply uncontrollably and metastasize to other body zones. Medicines based on radiotheranostics are frequently used in cancer treatment as they represent the pinnacle of personalized medicine, utilizing paired diagnostic and therapeutic radionuclide probes for the detection and treatment of specific cells, typically cancerous ones. Each treatment strategy is tailored to the patient's specific condition to improve the treatment's efficiency and yield better clinical outcomes. As an example, the American Cancer Society, a nonprofit cancer advocacy organization based in the United States, reported a rise in cancer cases from 1,958,310 in 2023 to 2,001,140 in January 2024, an increase of 2.19%. As such, the escalating incidence of cancer is fueling the growth of the radiotheranostics market.
Which Companies Hold the Largest Share Across Different Radiotheranostics Market Segments?
Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.
What Trends Are Driving Growth in The Radiotheranostics Market?
A key trend emerging in the radiotheranostics market is the emphasis on product innovation. Majority companies are focusing on the development of innovative products to solidify their market position. For instance, Advanced Cyclotron Systems Inc., a company headquartered in Canada that widely supplies and provides services for cyclotrons used in producing medical isotopes, launched TR-ALPHA in May 2023. This solution was conceived to meet the market's need for a budget-friendly cyclotron that can produce large quantities of Astatine-211, a rather promising alpha-emitting radioisotope in cancer treatment. Besides being smaller, less expensive, and easier to operate, TR-ALPHA compares favorably to previous models that manufactured alpha-emitting radioisotopes. This makes it the perfect choice for hospitals, researchers and organizations seeking to operate a dedicated cyclotron to efficiently produce high volumes of therapeutic alpha-emitting radioisotopes.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/radiotheranostics-global-market-report
What Are the Emerging Geographies for The Radiotheranostics Market Growth?
North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Radiotheranostics Market?
2. What is the CAGR expected in the Radiotheranostics Market?
3. What Are the Key Innovations Transforming the Radiotheranostics Industry?
4. Which Region Is Leading the Radiotheranostics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiotheranostics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4000567 • Views: …
More Releases from The Business Research Company
Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market: …
The Single-Cell Genome Sequencing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Single-Cell Genome Sequencing Market Size During the Forecast Period?
There has been a swift expansion in the single-cell genome sequencing market size over the past few years. The market is…
Signal Conditioning Modules Industry Report 2025-2034: Market Dynamics, Trends, …
The Signal Conditioning Modules Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Signal Conditioning Modules Market Size During the Forecast Period?
The market size for signal conditioning modules has been showing consistent growth in the past few years. There is an expectation…
Evolving Market Trends In The Self Service Coffee Machine Industry: Innovative P …
The Self Service Coffee Machine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Self Service Coffee Machine Market Size During the Forecast Period?
The market size for self-service coffee machines has seen considerable expansion in the previous years. It is projected to…
Rising Popularity Of Water Sports To Drive Market Growth: Key Factor Driving The …
The Scuba Diving Equipment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Scuba Diving Equipment Market Size During the Forecast Period?
The market size for scuba diving equipment has been experiencing a steady increase in recent years. The market is projected to…
More Releases for Radiotheranostics
Rise in Prevalence of Cancer will Drive Radiopharmaceutical Theranostics Market
Radiopharmaceutical Theranostics Market: Introduction
According to the report, the global radiopharmaceutical theranostics market was valued at US$ 0.84 Bn in 2020 and is projected to expand at a CAGR of 11% from 2021 to 2031. Nuclear medicine imaging is primarily based on the principle of using radioactive isotopes attached to specific molecules (i.e., radiopharmaceutical agents or radiotracers) to examine key biologic processes, including disease pathophysiology. Radiopharmaceuticals are agents used for both diagnostic and therapeutic purposes. Organizations across the world classify these differently.…
Nancyclotep has obtained €7 million in funding and has partnered with PMB to s …
Nancyclotep has embarked in a significant investment program to become a reference center for vectorized internal radiation therapy in France. In order to further establish its position, Nancyclotep has partnered with PMB, a subsidiary of the ALCEN group, which manufactures small cyclotrons and automated robotic systems for producing radiopharmaceuticals.
Together, the two entities obtained a European funding of €7.2 million. This global project, totaling more than €15 M, will allow the…
Nancyclotep is positioning itself to become the reference center for Vectorized …
Nancyclotep, a provider of solutions for the transfer of radiopharmaceuticals to the clinical setting, has announced its intention to become the reference center for Vectorized Internal Radiotherapy for the Greater East region, in collaboration with the University Hospital of Nancy and the support of the Regional Health Agency. A substantive investment will allow a significant increase in the number of shielded-rooms for patients in the short term, in conjunction with…
Most promising radiopharmaceuticals on the market by 2024-2026
MEDraysintell releases a new report covering the most promising radiopharmaceuticals (radiodiagnostics, radiotherapeutics and radiotheranostics) currently in clinical stage development which have the highest chances to reach the market by 2024-2026.
This new report covers 35 products along with the profile of the 27 companies developing these products, and aims to advice on the potential for investments, merger and acquisitions (M&A), technology and market development existing in this healthcare technology.
Detailed table of…
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than 390 products, including over 140 radiopharmaceuticals under clinical development, with a comprehensive profile of 193 companies and institutions active in the radiopharmaceuticals industry.
Detailed table of contents and sample pages available upon request a peg@medraysintell.com
MEDraysintell estimates that the global market for nuclear medicine reached US$ 4.5…
